Lilly claims drug slows Alzheimer’s progression by 35 per cent in trial. However there are significant side effects that require our attention respecting the risk vs benefit and long-term outcomes.

Dr. Barry Dworkin

Medical Mythbusting Commentary for May 5, 2023

[display_podcast]

Source:
Lilly drug slows Alzheimer’s progression by 35 per cent in trial

Related posts:

  1. Do not hang your hat on an unapproved Alzheimer’s blood test.
  2. End of week wrap up: Not being able to stand on one legs means you die earlier?, Alzheimer an autoimmune disease?, and COVID vaccines saved millions of lives according to Lancet-published study.
  3. Discovery could explain why women are more likely to get Alzheimer’s
  4. New non-invasive tool can detect early stages of Alzheimer’s and Parkinson’s. However device is in prototype stage with further testing and evaluation to follow.